These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 34439774)
1. Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy. Lee J; Han Y; Wang W; Jo H; Kim H; Kim S; Yang KM; Kim SJ; Dhanasekaran DN; Song YS Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439774 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade. Genova C; Dellepiane C; Carrega P; Sommariva S; Ferlazzo G; Pronzato P; Gangemi R; Filaci G; Coco S; Croce M Front Immunol; 2021; 12():799455. PubMed ID: 35069581 [TBL] [Abstract][Full Text] [Related]
3. Phytochemicals in regulating PD-1/PD-L1 and immune checkpoint blockade therapy. Zhang Q; Yang C; Gao X; Dong J; Zhong C Phytother Res; 2024 Feb; 38(2):776-796. PubMed ID: 38050789 [TBL] [Abstract][Full Text] [Related]
4. Assessing the Impact of Phytochemicals on Immune Checkpoints: Implications for Cancer Immunotherapy. Power Coombs MR; Hoskin DW Methods Mol Biol; 2020; 2111():161-173. PubMed ID: 31933207 [TBL] [Abstract][Full Text] [Related]
5. Co-inhibitory immune checkpoints in head and neck squamous cell carcinoma. Deng WW; Wu L; Sun ZJ Oral Dis; 2018 Mar; 24(1-2):120-123. PubMed ID: 29480599 [TBL] [Abstract][Full Text] [Related]
6. Focus on immune checkpoint PD-1/PD-L1 pathway: New advances of polyphenol phytochemicals in tumor immunotherapy. Liu K; Sun Q; Liu Q; Li H; Zhang W; Sun C Biomed Pharmacother; 2022 Oct; 154():113618. PubMed ID: 36055113 [TBL] [Abstract][Full Text] [Related]
7. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas. Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905 [TBL] [Abstract][Full Text] [Related]
8. Anticancer natural products targeting immune checkpoint protein network. Chun KS; Kim DH; Raut PK; Surh YJ Semin Cancer Biol; 2022 Nov; 86(Pt 3):1008-1032. PubMed ID: 34838956 [TBL] [Abstract][Full Text] [Related]
9. DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer. Sasidharan Nair V; El Salhat H; Taha RZ; John A; Ali BR; Elkord E Clin Epigenetics; 2018; 10():78. PubMed ID: 29983831 [TBL] [Abstract][Full Text] [Related]
10. Pivotal role of PD-1/PD-L1 immune checkpoints in immune escape and cancer progression: Their interplay with platelets and FOXP3+Tregs related molecules, clinical implications and combinational potential with phytochemicals. Lee DY; Im E; Yoon D; Lee YS; Kim GS; Kim D; Kim SH Semin Cancer Biol; 2022 Nov; 86(Pt 3):1033-1057. PubMed ID: 33301862 [TBL] [Abstract][Full Text] [Related]
11. Immune checkpoint inhibitors associated cardiovascular immune-related adverse events. Jo W; Won T; Daoud A; Čiháková D Front Immunol; 2024; 15():1340373. PubMed ID: 38375475 [TBL] [Abstract][Full Text] [Related]
12. Lymphocyte-activation gene-3, an important immune checkpoint in cancer. He Y; Rivard CJ; Rozeboom L; Yu H; Ellison K; Kowalewski A; Zhou C; Hirsch FR Cancer Sci; 2016 Sep; 107(9):1193-7. PubMed ID: 27297395 [TBL] [Abstract][Full Text] [Related]
13. On the Horizon: Targeting Next-Generation Immune Checkpoints for Cancer Treatment. Tundo GR; Sbardella D; Lacal PM; Graziani G; Marini S Chemotherapy; 2019; 64(2):62-80. PubMed ID: 31387102 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the expression of the immune checkpoint molecules PD-1, CTLA4, TIM-3 and LAG-3 across different cancers in relation to treatment response, tumor-infiltrating immune cells and survival. Tu L; Guan R; Yang H; Zhou Y; Hong W; Ma L; Zhao G; Yu M Int J Cancer; 2020 Jul; 147(2):423-439. PubMed ID: 31721169 [TBL] [Abstract][Full Text] [Related]
15. Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies. Pérez-Ruiz E; Melero I; Kopecka J; Sarmento-Ribeiro AB; García-Aranda M; De Las Rivas J Drug Resist Updat; 2020 Dec; 53():100718. PubMed ID: 32736034 [TBL] [Abstract][Full Text] [Related]
16. Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment. Gorris MAJ; Halilovic A; Rabold K; van Duffelen A; Wickramasinghe IN; Verweij D; Wortel IMN; Textor JC; de Vries IJM; Figdor CG J Immunol; 2018 Jan; 200(1):347-354. PubMed ID: 29141863 [TBL] [Abstract][Full Text] [Related]
17. Immune Checkpoints as the Immune System Regulators and Potential Biomarkers in HIV-1 Infection. Sperk M; Domselaar RV; Neogi U Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987244 [TBL] [Abstract][Full Text] [Related]
18. News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors. Melaiu O; Lucarini V; Giovannoni R; Fruci D; Gemignani F Semin Cancer Biol; 2022 Feb; 79():18-43. PubMed ID: 32659257 [TBL] [Abstract][Full Text] [Related]
19. T cell checkpoint regulators in the heart. Grabie N; Lichtman AH; Padera R Cardiovasc Res; 2019 Apr; 115(5):869-877. PubMed ID: 30721928 [TBL] [Abstract][Full Text] [Related]
20. Targeting the tumor microenvironment to overcome immune checkpoint blockade therapy resistance. Li Y; Liu J; Gao L; Liu Y; Meng F; Li X; Qin FX Immunol Lett; 2020 Apr; 220():88-96. PubMed ID: 30885690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]